Market research
FRHN.F Innovative Pharmaceutical Biotech Limited
F EUR Not available
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 34M
- P/E ratio
- 23.0
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- -0.14
Community
Investor discussion
1 comment
Sign in to join the FRHN.F discussion.
5 years, 5 months ago
Innovative Pharmaceutical Biotech Limited is currently in a long term downtrend where the price is trading 18.9% below its 200 day moving average.
From a valuation standpoint, the stock is 71.5% cheaper than other stocks from the Consumer Defensive sector with a price to sales ratio of 32.2.
Innovative Pharmaceutical Biotech Limited's total revenue sank by 0.0% to $6M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $-55M since the same quarter in the previous year.
Finally, its free cash flow grew by 30.4% to $-5M since the same quarter in the previous year.
Based on the above factors, Innovative Pharmaceutical Biotech Limited gets an overall score of 2/5.